ALK will market Rellergen's Bio-IC lab-on-a-chip technology to more than 190 hospitals in China. The technology uses a blood sample to screen up to 20 different allergens.
OncoDNA has recently signed a number of distribution agreements for its products, which include the OncoTrace and OncoSelect liquid biopsy tests.
Streck inked a three-year agreement with Van Xuan, a distributor with customers in public hospitals, private clinics, and pharma and manufacturing labs.
The companies will initially plan to acquire the required regulatory approvals in India for the Genedrive HCV ID kit.
Aker Bio's test is used for determining whether a patient being treated with heparin may be developing heparin-induced thrombocytopenia.
Under the agreement, Beckman Coulter will distribute the full range of Technopath Multichem QC products in more than 100 countries.
The deal comes as the firms try — for the second time — to close a merger that had previously failed to gain necessary approval from Rosetta shareholders.
The company is collating data on physician decision-making from early-access users, and believes that it can make a strong case for clinical utility of the test.
Rome-based Resnova will distribute Empire's FISH probes and molecular diagnostic services in Italy.
The Fondazione Luigi Maria Monti - Istituto Dermopatico dell' Immacolata research hospital in Rome will perform SelectMDx testing locally.